101 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
board of directors may either provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any … as they applied to such Restricted Stock; provided, however, that the Board may either provide for termination or deemed satisfaction of such repurchase or other
S-8
EX-5.1
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
satisfaction, of all pertinent records of the meetings of the board of directors and stockholders of the Company, the Registration Statement, the Plan
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
, risks and uncertainties related to the satisfaction of customary closing conditions related to the offering and the impact of general economic
8-K
EX-1.1
bvgdq
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
8-K
EX-4.1
lrjinmfrre3
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
zk9z9dq4
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K/A
EX-99.3
ijrb7m23nic
30 Nov 22
Financial Statements and Exhibits
6:46pm
S-8
EX-5.1
s45wypmivp7z7ltj9ur
16 Sep 22
Registration of securities for employees
7:50am